Clark Capital Management Group Inc. Has $113.42 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Clark Capital Management Group Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 224,207 shares of the healthcare conglomerate's stock after selling 13,619 shares during the quarter. UnitedHealth Group makes up 0.8% of Clark Capital Management Group Inc.'s investment portfolio, making the stock its 28th largest holding. Clark Capital Management Group Inc.'s holdings in UnitedHealth Group were worth $113,418,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after buying an additional 319,515 shares during the period. Capital International Investors grew its stake in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter valued at $6,375,744,000. Northern Trust Corp raised its stake in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on UNH shares. Truist Financial decreased their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research note on Monday, April 21st. Morgan Stanley reduced their price objective on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. KeyCorp reduced their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Stock Down 1.3 %

Shares of NYSE:UNH traded down $4.83 during trading on Friday, hitting $380.72. 8,371,190 shares of the company's stock traded hands, compared to its average volume of 4,708,365. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $346.54 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a 50-day moving average price of $488.01 and a 200-day moving average price of $522.60. UnitedHealth Group Incorporated has a 52 week low of $378.54 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the company posted $6.91 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.